Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles.
Capolla S, Colombo F, De Maso L, Mauro P, Bertoncin P, Kähne T, Engler A, Núñez L, Spretz R, Larsen G, Dal Bo M, Toffoli G, Macor P. Capolla S, et al. Among authors: macor p. J Nanobiotechnology. 2023 Oct 14;21(1):376. doi: 10.1186/s12951-023-02134-4. J Nanobiotechnology. 2023. PMID: 37838659 Free PMC article.
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.
Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G. Noris M, et al. Among authors: macor p. Blood. 2014 Sep 11;124(11):1715-26. doi: 10.1182/blood-2014-02-558296. Epub 2014 Jul 18. Blood. 2014. PMID: 25037630 Free PMC article. Clinical Trial.
Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab.
Ruffatti A, Tarzia V, Fedrigo M, Calligaro A, Favaro M, Macor P, Tison T, Cucchini U, Cosmi E, Tedesco F, Angelini A, Gerosa G. Ruffatti A, et al. Among authors: macor p. Autoimmun Rev. 2019 May;18(5):561-563. doi: 10.1016/j.autrev.2019.03.015. Epub 2019 Mar 4. Autoimmun Rev. 2019. PMID: 30844561 No abstract available.
The development of atypical hemolytic uremic syndrome depends on complement C5.
de Jorge EG, Macor P, Paixão-Cavalcante D, Rose KL, Tedesco F, Cook HT, Botto M, Pickering MC. de Jorge EG, et al. Among authors: macor p. J Am Soc Nephrol. 2011 Jan;22(1):137-45. doi: 10.1681/ASN.2010050451. Epub 2010 Dec 9. J Am Soc Nephrol. 2011. PMID: 21148255 Free PMC article.
Phage display technology for human monoclonal antibodies.
Deantonio C, Cotella D, Macor P, Santoro C, Sblattero D. Deantonio C, et al. Among authors: macor p. Methods Mol Biol. 2014;1060:277-95. doi: 10.1007/978-1-62703-586-6_14. Methods Mol Biol. 2014. PMID: 24037846
78 results